Table S2.
Subject demographic and clinical information
| Demographic | BD | HC | |||
| BD TOT | Manic BD | Depressed BD | Euthymic BD | ||
| Sample size n (%) | 60 (100) | 20 (33.3) | 20 (33.3) | 20 (33.3) | 40 (100) |
| Age (y) mean (SD) | 44.7 (11.2) | 46 (12) | 44.9 (10.9) | 43.1 (11) | 43.9 (12.8) |
| Female n (%) | 42 (70) | 17 (85) | 13 (65) | 12 (60) | 26 (65) |
| Age of onset mean (SD) | 25 (10.8) | 25 (12.3) | 25.3 (9.8) | 24.6 (10.9) | — |
| Duration of illness mean (SD) | 19.9 (11.6) | 21.7 (14.5) | 19.5 (10.8) | 18.2 (9) | — |
| HAM-D mean (SD) | — | 7 (5.4) | 21.5 (4) | 3.6 (2.8) | — |
| YMRS mean (SD) | — | 19 (5.7) | 4.2 (2.8) | 3.9 (2.7) | — |
| Mood stabilizers n (%) | 52 (86.7) | 16 (80) | 18 (90) | 18 (90) | — |
| Lithium n (%) | 16 (26.7) | 4 (20) | 5 (25) | 7 (35) | — |
| Valproate n (%) | 26 (43.3) | 10 (50) | 8 (40) | 8 (40) | — |
| Other antiepileptic drugs n (%) | 23 (38.3) | 5 (25) | 9 (45) | 9 (45) | — |
| Antidepressants n (%) | 22 (36.7) | 2 (10) | 11 (55) | 9 (45) | — |
| SRI n (%) | 10 (16.7) | 1 (5) | 6 (30) | 3 (15) | — |
| Tricyclic antidepressants n (%) | 6 (10) | 0 (0) | 4 (20) | 2 (10) | — |
| Duals and other antidepressants n (%) | 10 (16.7) | 1 (5) | 4 (20) | 5 (25) | — |
| Antipsychotics n (%) | 34 (56.7) | 14 (70) | 12 (60) | 9 (45) | — |
| Atypical n (%) | 29 (48.3) | 10 (50) | 13 (65) | 6 (30) | — |
| Typical n (%) | 7 (11.7) | 5 (25) | 1 (5) | 1 (5) | — |
| Benzodiazepines n (%) | 20 (33) | 5 (25) | 7 (35) | 8 (40) | — |
| Unmedicated n (%) | 2 (3.3) | 1 (5) | 0 (0) | 1 (5) | — |
SRI, serotonin reuptake inhibitors.